Black Diamond Therapeutics Inc (BDTX)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -24.1M | -21.56M | -20.03M | -24.01M | -20.86M | -20.25M | -22.13M | -18.13M |
税引前収入 | -21.08M | -20.88M | -19.15M | -23.01M | -19.41M | -18.23M | -19.91M | -15.56M |
純利益 | -21.08M | -20.88M | -19.15M | -23.01M | -19.41M | -18.23M | -19.91M | -15.56M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -21.76M | -21.5M | -19.63M | -23.45M | -19.73M | -18.86M | -20.37M | -16.07M |
EBITDA | -23.98M | -21.44M | -19.92M | -23.9M | -20.77M | -20.16M | -22.04M | -18.04M |
年末 2023年12月31日 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -4.12M | -8.9M | -29.33M | -69.57M | -126.87M | -95.08M | -86.46M |
税引前収入 | -4.6M | -8.93M | -35.26M | -67.25M | -125.6M | -91.17M | -82.44M |
純利益 | -4.6M | -8.93M | -35.26M | -67.25M | -125.6M | -91.17M | -82.44M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.702 | -1.334 | -15.761 | -1.864 | -3.466 | -2.502 | -1.597 |
EBIT | -4.41M | -8.92M | -29.33M | -71.29M | -129.06M | -93.2M | -84.37M |
EBITDA | -4.1M | -8.86M | -29.29M | -69.52M | -126.67M | -94.57M | -86.02M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約